Today: 1 July 2026
Browse Category

NZX:ANZ 3 December 2025

New Zealand Stock Market Outlook for 4 December 2025: 10 Things to Know Before the NZX Opens

New Zealand Stock Market Outlook for 4 December 2025: 10 Things to Know Before the NZX Opens

The New Zealand sharemarket heads into Thursday’s open on the back of a two‑day rally, a fresh Fonterra update, and growing optimism that global central banks are done with aggressive tightening. Here’s a detailed look at what’s likely to shape trading on Thursday, 4 December 2025. Below, we unpack the moving parts.
3 December 2025
······

Stock Market Today

  • Telix Pharmaceuticals (ASX:TLX) leans on vertical integration for expansion push
    July 1, 2026, 8:14 AM EDT. Telix Pharmaceuticals (ASX:TLX) reported more commercial momentum and wider global footprint in radiopharmaceuticals on a June 2026 call. Management is focused on vertical integration, controlling its own manufacturing and distribution, to get a lasting edge in precision oncology. Its deal with Regeneron adds to a string of partnerships, but the company still faces pricing pressure and regulatory hurdles. Telix forecasts revenue of A$1.2 billion and A$81.9 million in earnings by 2029, about 37% above the current share price. Profitability could remain under strain as R&D and buildout costs stay high, and investors are told to be mindful of these risks against growth plans and pipeline deals.
Go toTop